GI Lecture 15: Esophagus & Stomach Disease
HoyaDocs — GI Block | USMLE Step 1 Preparation
GI Lecture 15 — Overview
Esophagus & Stomach Disease · HoyaDocs GI Block
Page Summaries
Infectious esophagitis (HSV, CMV, Candida) · GERD · Barrett's esophagus · SCC · Adenocarcinoma
Practice Qs: 1–5
Acute vs. chronic gastritis · H. pylori vs. autoimmune · Erosion vs. ulcer · PUD pathogenesis, predisposing factors, complications, treatment
Practice Qs: 6–10
Precancerous lesions · Gastric carcinoma (Lauren classification) · GIST (c-KIT) · MALT lymphoma · H. pylori disease associations
Practice Qs: 11–15
Antral gastritis · PUD (duodenal > gastric ulcer) · Intestinal metaplasia · Gastric adenocarcinoma · MALT lymphoma
Key Step 1 organism to master
Official Learning Objectives Map
Esophageal Diseases
LOs 1–3 · Infectious Esophagitis · GERD · Barrett's · SCC · Adenocarcinoma
- LO 1: List common infectious etiologies of esophagitis — clinical setting, histologic findings, complications (HSV, CMV, Candida)
- LO 2: Describe pathophysiology and clinical symptoms of reflux esophagitis; identify defining histologic features; list potential complications
- LO 3: Describe epidemiology, presentation, pathologic features, and biologic behavior of esophageal SCC and adenocarcinoma
▼ Infectious Esophagitis
Esophagitis is inflammation of the esophageal mucosa caused by physical, chemical, or biologic agents. Infectious esophagitis is uncommon in the general population but frequently affects immunosuppressed patients (chemotherapy recipients, HIV/AIDS, organ transplant patients).
- HSV — viral; squamous cells at ulcer margin
- CMV — viral; endothelial cells and fibroblasts at ulcer base
- Candida albicans — fungal; most common overall; diabetic/immunosuppressed patients
Herpes Simplex Virus (HSV)
Clinical setting: Most common cause of viral esophagitis. Patients with visceral herpes generally have esophageal involvement. Occurs primarily in immunosuppressed patients, often after chemotherapy for cancer.
Endoscopic appearance: Shallow "herpetic" ulcers (requires biopsy to rule out malignancy).
Histologic findings: Viral cytopathic changes in squamous cells at the ulcer margin:
- Intranuclear viral inclusions
- Ground-glass nuclei
- Multinucleated giant cells
- Ballooning degeneration of infected cells
Molding · Multinucleation · Margination
All 3 refer to how viral inclusions appear in squamous nuclei at the ulcer margin.
Cytomegalovirus (CMV)
Clinical setting: Occurs in ulcers throughout the GI tract. Immunosuppression (especially organ transplant recipients, AIDS) predisposes.
Histologic findings: Large nuclear and cytoplasmic inclusions in endothelial cells and fibroblasts at the ulcer base (not squamous cells as in HSV).
- HSV: inclusions in squamous cells at ulcer margin → "Molding, Multinucleation, Margination"
- CMV: inclusions in endothelial cells/fibroblasts at ulcer base → "Owls-eye" appearance
Candida albicans (Fungal Esophagitis)
Clinical setting: Most common cause of fungal esophagitis. Usually found in diabetic, immunosuppressed, or antibiotic-treated patients.
Endoscopic appearance: Yellow-white plaques with mucosal ulceration; umbilicated mucosal lesions with little inflammatory response.
Histologic findings: Fibrinopurulent exudate containing organisms; pseudohyphae should be seen in tissue sections (GMS stain). Yeast forms are common surface contaminants — not diagnostic alone.
Candida is NOT typically biopsied for diagnosis (endoscopic appearance + clinical setting is usually sufficient). When biopsied, look for pseudohyphae on GMS stain — yeast forms on the surface are common contaminants and not diagnostic.
▼ Reflux Esophagitis (GERD)
Reflux esophagitis is the most important and most common form of esophagitis. It results from reflux of gastric juices into the lower esophagus, most frequently due to hiatus hernia, but also alcoholism, scleroderma, recurrent vomiting, and diseases affecting the lower esophageal sphincter (LES).
GERD → Barrett's Esophagus (metaplasia) → Low-grade dysplasia → High-grade dysplasia → Adenocarcinoma
Pathophysiology
Chronic reflux of acidic gastric contents damages the esophageal squamous epithelium. The body responds with a reactive/reparative process involving basal cell hyperplasia and elongation of vascular papillae (Rete pegs — indicating chronic stress).
Histologic Features of Reflux Esophagitis
- Inflammation: Neutrophils (acute) and eosinophils in the epithelium
- Hyperplasia: Thickening of the basal layer (>15%); elongation of papillae of the lamina propria (above the 50% level) — extension of Rete pegs
- Ulceration: Peptic ulcers; can lead to perforation and bleeding
- Scarring: Narrowing with strictures, rings, and webs
- Glandular metaplasia: Barrett's esophagus — sequel to long-standing reflux
GERD is NOT often biopsied at the reflux esophagitis stage (except to rule out eosinophilic esophagitis in some pediatric patients). Biopsy becomes critical when Barrett's or dysplasia is suspected.
Clinical Symptoms
- Heartburn (pyrosis) — burning substernal discomfort
- Dysphagia — difficulty swallowing (if strictures develop)
- Regurgitation
- Symptoms worsen when lying down or after eating
Complications of Reflux Esophagitis
- Strictures, rings, webs (from scarring)
- Peptic ulceration with bleeding/perforation
- Barrett's esophagus (~10% of symptomatic GERD) — most important complication
- Esophageal adenocarcinoma (via Barrett's)
▼ Barrett's Esophagus
Barrett's esophagus (BE) is a complication of long-standing gastroesophageal reflux, occurring in up to 10% of patients with symptomatic GERD. It is the single most important risk factor for esophageal adenocarcinoma.
- Normal stratified squamous epithelium → simple columnar epithelium with goblet cells (intestinal metaplasia)
- Two criteria for diagnosis: (1) Endoscopic evidence of columnar epithelium above GE junction AND (2) histologic evidence of intestinal metaplasia (goblet cells) in biopsy
- Majority of esophageal adenocarcinomas arise in Barrett's epithelium
- Endoscopic appearance: irregular mucosa at GE junction — "salmon" tongues
- Requires chronic endoscopic surveillance
Dysplasia Management
- BE without dysplasia: Regular endoscopic surveillance
- BE + low-grade dysplasia: Watch and wait / closer surveillance
- BE + high-grade dysplasia: Ablation/removal (endoscopic or surgical) — high risk of progression to carcinoma
Barrett's esophagus is a precancerous LESION (not just a condition). Dysplasia develops in the metaplastic tissue and can become adenocarcinoma in up to 10% of Barrett's cases. The presence of goblet cells on histology is the diagnostic sine qua non — without goblet cells, it is NOT Barrett's esophagus.
▼ Esophageal Squamous Cell Carcinoma (SCC)
Squamous cell carcinoma represents most esophageal malignancies globally. Most occur in the distal two-thirds of the esophagus.
Epidemiology & Risk Factors
- Achalasia
- Chronic esophagitis
- Alcohol and tobacco use
- Strictures
- Unrelated to GERD/Barrett's — distinct from adenocarcinoma
- SCC: Middle third of esophagus (associated with smoking/alcohol/achalasia)
- Adenocarcinoma: Lower third / GE junction (associated with GERD/Barrett's)
Pathologic Features
Gross: Ulcerated mass with overhanging margin; may be flat, annular, polypoid, nodular, or diffuse.
Microscopic: Squamous cell carcinomas are generally well-differentiated; may show submucosal infiltration laterally beyond what is visible grossly. Well-differentiated tumors may show squamous pearls. Immunostain: p63/CK5/6 positive.
Clinical Presentation & Prognosis
Symptoms are late: Progressive obstruction leads to dysphagia (difficulty swallowing). Tracheoesophageal fistulas occur in up to 10% of esophageal carcinomas.
Prognosis: Survival strongly depends on anatomic extent (stage). Esophageal carcinoma overall has the poorest prognosis of all digestive tract cancers — less than 10% 5-year survival.
▼ Esophageal Adenocarcinoma
About 15% of esophageal malignant tumors; most are located in the lower third of the esophagus, comprising over 40% of cancers there. Most arise in Barrett's esophagus.
Epidemiology & Risk Factors
- Most common in men with GERD/Barrett's esophagus
- Located at the gastroesophageal (GE) junction
- Incidence rising in Western countries (linked to obesity and GERD)
- High-risk patients require routine surveillance endoscopy
Pathologic Features
Gross: Large mass protruding into esophageal lumen.
Microscopic: Hyperchromatic back-to-back glands moving through and degrading normal tissue. Histologic subtypes (same as gastric carcinoma):
- Gland-forming adenocarcinoma (tubular and papillary patterns)
- Mucinous adenocarcinoma
- Signet ring cell type
Immunostain: Mucin-positive (glands make mucin) — distinguishes from SCC.
Prognosis
- 80% survival when adenocarcinoma limited to mucosa/submucosa (early stage)
- <25% survival in advanced (symptomatic) stages
- Dysplasia appears to precede carcinoma (analogous to dysplasia in atrophic gastritis and ulcerative colitis)
- Surveillance is by endoscopic biopsy in high-risk patients
| Feature | Squamous Cell Carcinoma | Adenocarcinoma |
|---|---|---|
| Location | Middle third | Lower third / GE junction |
| Risk factors | Alcohol, tobacco, achalasia, strictures | GERD, Barrett's esophagus, obesity |
| Precursor | Chronic esophagitis / achalasia | Barrett's esophagus |
| Microscopy | Squamous pearls; p63/CK5/6+ | Glands, goblet cells, mucin+ |
| Demographics | Developing countries; smoking populations | Western countries; men with GERD |
| Prognosis | <10% 5-year survival overall | Stage-dependent; 80% if early, <25% if late |
Gastritis & Peptic Ulcer Disease
LOs 4–8 · Acute & Chronic Gastritis · H. pylori vs. Autoimmune · Erosion vs. Ulcer · PUD
- LO 4: Define acute gastritis; list potential causes; describe clinical and pathologic features
- LO 5: Distinguish erosion vs. ulcer; describe histologic patterns of gastritis
- LO 6: Compare chronic gastritis caused by H. pylori vs. autoimmune etiology
- LO 7: Characterize PUD — pathogenesis, mechanisms, predisposing factors, pathologic features, complications
- LO 8: Describe healing of ulcers and identify treatment options for PUD
▼ Acute Gastritis
Acute gastritis = inflammation of the gastric mucosa. Clinically, "gastritis" is used loosely to cover epigastric pain, heartburn, nausea, and vomiting (dyspepsia). Ultimately, gastritis results from an imbalance between damaging forces and defensive forces.
Causes of Acute Gastritis
Infectious:
- Bacterial: H. pylori
- Fungal: Candida
- Viral: CMV
Chemical (gastropathy):
- Alcohol
- NSAIDs (aspirin and other nonsteroidal anti-inflammatory drugs)
- Bile reflux
- Peptic enzymes
- Stress (burns → Curling ulcer; cerebral lesions → Cushing ulcer)
Morphologic Features
- Edema, hyperemia, increased mucus secretion
- Erosions and hemorrhage can occur
- Neutrophilic infiltrate (hallmark of acute gastritis)
- Mucosal regeneration without scarring is usual (resolves completely)
▼ Chronic Gastritis & Histologic Patterns
Chronic gastritis = chronic inflammation of the gastric mucosa, associated with glandular atrophy and intestinal metaplasia. Relation to acute gastritis is unclear. Low mortality, high morbidity. Causes: Helicobacter pylori (#1) and autoimmune process.
Four Histologic Patterns of Gastritis
| Pattern | Description | Key Feature |
|---|---|---|
| Chronic gastritis | Mucosa infiltrated with chronic inflammatory cells; surface epithelium has reduced mucus; no loss of glands | H. pylori often found in surface mucus |
| Atrophic gastritis | Chief and parietal cells replaced by simple mucus-secreting cells; chronic inflammation; polypoid hyperplasia may occur | Loss of specialized cells |
| Intestinal metaplasia | Transformation of gastric glands to those resembling intestinal mucosa with acid mucin-containing goblet cells | Goblet cells (like Barrett's) |
| Gastric atrophy | Extensive (not focal) thinning of mucosa with loss of acid- and pepsin-secreting glands; replaced by mucus glands and intestinal metaplasia | Precancerous state; pernicious anemia risk |
Intestinal metaplasia in the stomach (goblet cells in gastric glands) is a precancerous change — similar conceptually to Barrett's esophagus. Both represent columnar metaplasia with goblet cells under chronic injury. Active acute inflammation (neutrophils) superimposed = active destructive disease.
▼ H. pylori vs. Autoimmune Gastritis — Comparison
Two main causes of chronic gastritis — distinguished by location, mechanism, serology, and sequelae. This comparison table is heavily tested on Step 1.
| Feature | H. pylori-Associated | Autoimmune |
|---|---|---|
| Location | Antrum (antrum → pangastritis) | Body/Fundus (antrum-sparing) |
| Inflammatory infiltrate | Neutrophils, subepithelial plasma cells | Lymphocytes, macrophages |
| Acid production | Increased to slightly decreased | Decreased (parietal cell destruction) |
| Gastrin level | Normal to decreased | Increased (↓ acid → ↑ G-cell stimulation) |
| Other lesions | Hyperplastic/inflammatory polyps | Neuroendocrine (ECL cell) hyperplasia |
| Serology | Antibodies to H. pylori | Antibodies to parietal cells (H⁺/K⁺-ATPase, intrinsic factor) |
| Sequelae | Peptic ulcer, adenocarcinoma, MALT lymphoma | Pernicious anemia, adenocarcinoma, carcinoid tumor |
| Associations | Residence in rural/developing areas | Other autoimmune diseases (thyroiditis, diabetes, Graves') |
Autoantibodies → destroy parietal cells → ↓ HCl + ↓ intrinsic factor → (1) Pernicious anemia (↓ B12 absorption) + (2) ↑ Gastrin (G cells not inhibited) → ECL cell hyperplasia → carcinoid/neuroendocrine tumor risk. The type of hormone secreted by the tumor determines the symptoms.
H. pylori is typically found in the antrum on histology (Warthin-Starry silver stain shows spiral-shaped bacteria in surface mucus). However, H. pylori can cause pangastritis (all-over inflammation) → atrophy and intestinal metaplasia → carcinoma risk. Autoimmune gastritis is antrum-sparing — if you see body/fundus involvement with pernicious anemia, think autoimmune, not H. pylori.
▼ Erosion vs. Ulcer
- Erosion = partial focal loss of mucosa (less than full thickness); can progress to ulcer or heal without scarring
- Ulcer = focal area of full thickness destruction of mucosa; extends into submucosa, muscularis; may perforate
Peptic ulcers occur only where gastric secretions have access. Unlike other GI ulcers (infections, ischemia), peptic ulcers are specifically caused by an autodigestive process.
Gross Features of Peptic Ulcer
- Sharply defined, clear-cut edges with abrupt drop into the crater
- Edges are not raised, rolled, or heaped up (raised edges = feature of carcinoma)
- Mucosa overhangs
- Most less than 2 cm
Peptic ulcer: flat, sharp, overhanging edges; crater with abrupt walls; <2 cm.
Gastric carcinoma (ulcerating type): raised, irregularly thickened edges; large shallow bumpy crater; distinct nodular appearance. Always biopsy a gastric ulcer to rule out cancer.
▼ Peptic Ulcer Disease (PUD)
PUD = focal destruction of mucous membrane and underlying tissues by gastric digestive juices. It is one of the few examples of an autodigestive lesion. Related to abnormalities in (1) the level of acid secretions and (2) the protective cellular and mucous coating.
Mechanisms of Peptic Ulceration
- Hyperacidity: Controlled by gastrin, histamine, vagus nerve, acetylcholine. Duodenal ulcer is more related to hyperacidity and H. pylori.
- Decreased mucosal protection: Mucosal damage, decreased mucus viscosity, vascular shunts, decreased cell cohesion. Gastric ulcer is more related to mucosal weakness and NSAIDs.
- Altered motility: Affects mixing of acid with neutralizing secretions in the duodenum.
Predisposing Factors
| Factor | Details |
|---|---|
| H. pylori (#1) | Gastric infection; direct mucosal injury + increased acid secretion + inflammatory reaction → ulcer production |
| NSAIDs (#2) | Major cause of erosions and ulcers in stomach and intestines; inhibit protective prostaglandins |
| Stress | Burns → Curling ulcer; following surgery/fractures/trauma |
| Cerebral lesions | Especially hypothalamus; vagus nerve controls acid secretion → vagotomy is treatment |
| Tobacco smoking | Impairs mucosal protection |
| Hormones | Increased adrenocortical steroids, gastrin, glucagon, parathyroid secretions |
| Zollinger-Ellison syndrome | Gastrinoma (pancreas/stomach/intestine) → severe peptic ulceration, often multiple; marked hyperacidity |
| Genetic factors | Family history; blood group O |
Topography of Peptic Ulcers
- Esophagus: Distal esophagus — associated with hiatus hernia/reflux
- Stomach: Chronic ulcers in pyloric type mucosa; lesser curvature or antrum (rarely body/greater curvature). Acute ulcers and erosions can occur in body mucosa.
- Duodenum: First part, anterior or posterior wall. In Zollinger-Ellison → distal duodenum and even jejunum
- Duodenal > gastric in young adults; gastric more common in elderly
Microscopic Appearance of Chronic Peptic Ulcer (4 Layers)
- Fibrinopurulent exudate on surface
- Necrotic tissue (coagulative necrosis)
- Granulation tissue: capillaries, fibroblasts, chronic inflammation
- Scar: muscle replaced by fibrous tissue; muscularis propria and muscularis mucosae fuse at edges; vessels thrombosed (endarteritis obliterans)
Note: Lymphoid aggregates are associated with H. pylori (not NSAIDs).
Complications of Peptic Ulcer
- Perforation: More common in acute than chronic ulcers (scar in chronic ulcer resists perforation). Anterior perforation → severe peritonitis + shock. Posterior perforation → penetration into pancreas.
- Hemorrhage: Accompanies all ulcers (erosion of capillaries); massive hemorrhage follows erosion of large vessels → exsanguination. More typical of duodenal than gastric ulcers.
- Obstruction: Scarring can deform gastric outlet → gastric outlet obstruction.
Perforation · Hemorrhage · Pylon obstruction (outlet obstruction)
▼ Healing & Treatment of PUD
Healing Process
Epithelium grows in from the sides → covers surface → grows down as tubules. Scars develop from granulation tissue. Repeated episodes of ulceration and healing occur (chronic, relapsing nature).
- Acute ulcer: No scar; often multiple; occurs anywhere (body and antrum)
- Chronic ulcer: Muscle destroyed and replaced by scar; usually single; submucosa thickened by scar; usually in antrum
Treatment Options
| Treatment | Mechanism | Notes |
|---|---|---|
| H. pylori eradication | Triple therapy (PPI + 2 antibiotics) | Cornerstone of treatment; can cure PUD |
| Proton pump inhibitors (PPIs) | Block H⁺/K⁺-ATPase → ↓ acid secretion | Most potent acid suppressants |
| H2 receptor antagonists | Block histamine H2 receptors → ↓ acid secretion | e.g., ranitidine, famotidine |
| Antacids | Neutralize existing acid | Symptomatic relief only |
| Vagotomy | Reduces vagal stimulation of acid secretion | Historical/surgical; rarely used today |
For H. pylori-positive PUD: eradicate H. pylori + PPI. Incidence of chronic peptic ulcer has been decreasing over 20 years — likely related to H. pylori treatment and antisecretory medications.
Gastric Tumors & Cancer
LOs 9–13 · Precancerous Lesions · Gastric Carcinoma · GIST · MALT Lymphoma · H. pylori Associations
- LO 9: List and discuss pre-cancerous lesions of the stomach
- LO 10: Describe macroscopic and microscopic types of gastric carcinoma; distinguish intestinal vs. diffuse (Lauren classification); identify prognostic factors
- LO 11: Characterize pathogenesis and prognostic features of GIST
- LO 12: List types of lymphoma arising in the stomach and describe pathologic/clinical features
- LO 13: List and describe gastric diseases associated with H. pylori
▼ Precancerous Lesions of the Stomach
Several conditions are associated with an increased risk of gastric cancer. Knowing the distinction between a lesion (structural change that itself can become cancer) and a condition (background state that increases cancer risk) is important.
| Precancerous Entity | Type | Mechanism / Notes |
|---|---|---|
| Epithelial dysplasia | Lesion | Most highly selective precancerous lesion; cytologic changes (enlarged, hyperbasophilic, crowded nuclei); histologic changes (irregular glands). Graded low/high. |
| Adenomas | Lesion | Precancerous lesion; uncommon in stomach vs. colon; present as polyps |
| Intestinal metaplasia | Condition | Goblet cells in gastric glands; associated with gastric carcinoma at population, patient, and topographic level |
| Atrophic gastritis | Condition | Frequently associated with gastric carcinoma, adenoma, and pernicious anemia |
| H. pylori infection | Condition | Causes chronic atrophic gastritis → intestinal metaplasia → carcinoma and MALT lymphoma |
| Pernicious anemia | Condition | May be mediated through increased frequency of dysplasia in atrophic gastritis |
| Ménétrier disease | Condition | Giant rugal hypertrophy, greatly thickened gastric folds, increased mucous glands, proximal stomach; protein loss, anemia |
| Gastric peptic ulcer | Lesion (low risk) | Not high risk; cancer arises at ulcer edge (not base); shows typical scars of chronic ulcer at cancer margin |
▼ Gastric Carcinoma
Gastric carcinoma has interesting epidemiology: incidence varies geographically and with socioeconomic status; appears more related to diet than most other cancers; highest incidence in Japan, Iceland, Finland, Chile. Gastric cancer incidence has fallen dramatically in North America over the past 50 years — potentially due to improved food safety (refrigeration) and declining H. pylori rates. Smoked foods, salted foods, low fresh vegetable diet, and nitrosamines are associated with high gastric cancer rates.
Macroscopic Types of Gastric Carcinoma
| Macroscopic Type | Description | Notes |
|---|---|---|
| Nodular | Focal raised, but not very polypoid, mass | Common |
| Ulcerating | Large shallow bumpy crater with raised, irregularly thickened edges | Common; distinct from peptic ulcer (which has flat sharp edges). Nodular and ulcerating often mixed. |
| Fungating | Protuberant plant-like luminal mass | Uncommon |
| Linitis plastica | Diffusely spreading tumor with extensive fibrosis; thickens gastric wall without showing a localized mass ("leather bottle stomach") | Uncommon; biopsy difficult to assess (more scar than tumor); seen in young patients; signet ring cells |
Linitis plastica is the diffuse type of gastric carcinoma (Lauren classification). The stomach becomes rigid and non-distensible. Histologically shows signet ring cells (central mucous droplet, peripherally displaced nucleus) diffusely percolating throughout the tissue. More common in young patients, uniform worldwide distribution, does NOT require intestinal metaplasia precursor.
Common Microscopic Types
- Gland-forming adenocarcinoma: Tubular and papillary patterns; degree of differentiation = how closely tumor resembles non-neoplastic epithelium (well, moderately, and poorly differentiated)
- Signet ring cell carcinoma: Individual cells with central mucous droplet and peripherally displaced nucleus; poorly differentiated; usually seen in linitis plastica
- Mucinous adenocarcinoma: Adenocarcinoma with >50% mucin
Lauren Classification of Gastric Carcinoma
| Feature | Intestinal Type | Diffuse Type |
|---|---|---|
| Growth pattern | Forms glands; grows as well-demarcated mass | Individual/small groups of poorly differentiated infiltrative cells spread diffusely through the wall |
| Macro appearance | Mass protruding into stomach lumen | Entire stomach becomes rigid (no localized mass) = linitis plastica |
| Microscopy | Neoplastic glands and goblet cells (like colonic adenocarcinoma) | Signet-ring cells diffusely percolating throughout tissue |
| Epidemiology | Predominant in high-incidence areas (Japan); older age group; males > females | Uniformly distributed worldwide; mean age under 50; equal sex distribution |
| Precursor lesion | Strongly associated with intestinal metaplasia | NOT strongly associated with intestinal metaplasia |
| Prognosis | Relatively better | Poor; difficult to resect |
Spread & Prognosis
Spread: Gastric carcinoma invades the wall → spreads to regional lymph nodes. Direct spread into neighboring organs (pancreas, liver) is common, as is spread on peritoneal surfaces. Tumors at the cardia frequently invade the esophagus; spread into duodenum is less common. Most common distant metastasis site = liver.
Prognosis: Poor because of relatively late diagnosis. Related to depth of invasion and presence of lymph node and distant metastasis. 29% overall 5-year survival — was the leading cause of cancer deaths but has declined since the 1980s.
▼ Gastrointestinal Stromal Tumors (GIST)
GISTs are mesenchymal tumors of the GI tract — the most common mesenchymal (stromal/smooth muscle) tumor of the abdomen, most commonly found in the stomach. The origin is unclear — features suggest precursor of smooth muscle or neurogenic (Cajal-cell) elements.
Gross & Histologic Features
- Arises within the muscular wall; usually projects into the lumen as a sessile mass
- Grossly: appear white/fleshy with intact mucosal layer
- Pressure on mucosa causes atrophy, then ulceration and bleeding
- Specific immunohistochemical profile (c-KIT positive)
Pathogenesis — c-KIT Mutation
- Highly associated with c-KIT tyrosine kinase gain-of-function mutations
- IHC staining used to identify GIST in path lab (c-KIT positive)
- Treatment: Imatinib (Gleevec) — inhibitor of c-KIT tyrosine kinase pathway; highly effective even in metastatic disease
Prognosis
It is frequently difficult to predict biologic behavior — benign-looking tumors may metastasize. Mitotic rate and size are the best indicators of metastatic potential. Generally less aggressive than carcinomas. Sensitive to imatinib even in cases with metastasis.
▼ Gastric Lymphoma & MALT
The GI tract is the main extranodal site of primary malignant lymphomas. Of these, the stomach is the #1 site (55% of GI lymphomas). Most are B-cell lymphomas arising from mucosa-associated lymphoid tissue (MALT) = MALTomas.
Distribution of GI Lymphomas
| Site | % of GI Lymphomas | 5-Year Survival |
|---|---|---|
| Stomach | 55% | 44% |
| Small intestine | 25% | 23% |
| Ileocecal | 15% | 13% |
| Colorectal | 5% | 5% |
Prognosis of gastric lymphoma is better than gastric carcinoma. Spread to lymph nodes/other organs is the main determinant of prognosis.
Histologic Features
- More often multifocal than carcinoma
- More common in the body (vs. carcinoma in antrum)
- Low-grade (small cell): Simulates chronic gastritis; lymphoid aggregates within the mucosa
- High-grade (large cell): Simulates carcinoma (distinction important — different treatment and prognosis)
- Macroscopic: cobblestoning/protrusion of lymphoid centers into gastric antrum
- H. pylori implicated as cause of gastric lymphoma: H. pylori injury → overstimulation/hyperplasia of lymphoid tissue → increased MALToma risk
- H. pylori eradication can sometimes CURE early low-grade MALT lymphomas — antibiotics as cancer treatment!
▼ H. pylori — Disease Associations Summary
Helicobacter pylori is a gram-negative, spiral-shaped bacterium found in the surface mucus of the gastric antrum. It is the most common bacterial infection worldwide and a WHO Class I carcinogen. Understanding its associations is critical for Step 1.
- Antral (H. pylori) gastritis — most common location; Warthin-Starry silver stain; acute + chronic inflammatory cells
- Duodenal ulcer — most common PUD type; more related to hyperacidity + H. pylori
- Gastric ulcer — less common than duodenal; more related to mucosal weakness
- Chronic atrophic gastritis → intestinal metaplasia (colon-like goblet cells, like Barrett's)
- Gastric adenocarcinoma — intestinal type; via atrophic gastritis → intestinal metaplasia → dysplasia → carcinoma
- MALT lymphoma (MALToma) — H. pylori eradication can cure early low-grade MALT lymphoma
- Duodenal ulcer (most common)
- Gastric ulcer
- Ulcerating gastritis (chronic)
- Adenocarcinoma (intestinal type)
- MALT lymphoma
Japanese migrants to Hawaii and California show a decreased gastric cancer incidence within one generation — supporting the role of environmental factors (diet, H. pylori prevalence) over purely genetic factors. This is a classic Step 1 epidemiology teaching point.
Practice Questions
15 USMLE-Style Questions · Esophagus & Stomach Disease
Question 1
A 45-year-old man on immunosuppressive therapy following renal transplantation develops odynophagia. Endoscopy reveals shallow ulcers in the esophagus. Biopsy shows viral cytopathic changes in squamous cells at the ulcer margin with multinucleated giant cells and intranuclear inclusions. Which of the following best describes these findings?
A) Candida esophagitis — pseudohyphae on GMS stain
B) CMV esophagitis — "owls-eye" inclusions in endothelial cells
C) HSV esophagitis — Molding, Multinucleation, Margination in squamous cells
D) Barrett's esophagus — goblet cell metaplasia
E) Reflux esophagitis — eosinophils and basal cell hyperplasia
The key findings are: (1) viral cytopathic changes in squamous cells at the ulcer margin, (2) multinucleated giant cells, and (3) intranuclear inclusions. This is the classic description of HSV esophagitis (3 M's: Molding, Multinucleation, Margination). CMV (B) shows "owls-eye" inclusions in endothelial cells and fibroblasts at the ulcer base — not squamous cells. Candida (A) shows pseudohyphae on GMS stain with white plaques endoscopically. The immunosuppressed transplant patient setting is consistent with multiple infectious causes, but the squamous cell location with multinucleated giant cells is the HSV signature.
Question 2
A 52-year-old obese man with a 15-year history of heartburn undergoes upper endoscopy. Irregular pinkish mucosa with "salmon-colored tongues" is seen extending above the gastroesophageal junction. Biopsy reveals columnar epithelium with goblet cells. Which of the following is the most important clinical implication of this finding?
A) Immediate surgical esophagectomy is required
B) This is a benign condition requiring no follow-up
C) This is the most important risk factor for esophageal adenocarcinoma
D) This finding is most consistent with squamous cell carcinoma of the esophagus
E) H. pylori eradication will cure this condition
This is a classic presentation of Barrett's esophagus — intestinal metaplasia (goblet cells) replacing the normal stratified squamous epithelium in the lower esophagus, occurring in the context of long-standing GERD. Barrett's is the single most important risk factor for esophageal adenocarcinoma. The diagnosis requires both endoscopic evidence AND histologic goblet cells. Management requires chronic endoscopic surveillance. Surgery is only indicated for high-grade dysplasia. H. pylori eradication treats MALT lymphoma and PUD, not Barrett's.
Question 3
A 68-year-old man with progressive difficulty swallowing presents for evaluation. Upper endoscopy reveals an ulcerated mass with overhanging margin in the middle third of the esophagus. He reports a 40 pack-year smoking history and drinks alcohol daily. Biopsy shows well-differentiated squamous cells with squamous pearl formation. Which feature best distinguishes this tumor from esophageal adenocarcinoma?
A) Location in the lower third of the esophagus
B) Association with Barrett's esophagus
C) Presence of mucin-positive glandular structures
D) Location in the middle third with p63/CK5/6-positive cells
E) Most common in obese patients with GERD
Esophageal SCC occurs predominantly in the middle third of the esophagus and is associated with smoking, alcohol, achalasia, and strictures. Immunostain: p63/CK5/6 positive (markers of squamous differentiation) — squamous pearls on histology confirm. Adenocarcinoma (A, B, C, E) occurs in the lower third / GE junction, arises from Barrett's esophagus in GERD patients, and shows mucin-positive glands. Both have <10% 5-year survival overall (poorest prognosis of all digestive tract cancers).
Question 4
A 35-year-old woman taking ibuprofen daily for chronic back pain presents with epigastric pain, nausea, and vomiting. Upper endoscopy shows mucosal edema, hyperemia, and small hemorrhagic erosions in the gastric body. Biopsy reveals a neutrophilic infiltrate. Which of the following correctly describes the key difference between this finding and a chronic peptic ulcer?
A) Erosion extends through the full thickness of the mucosa
B) Erosion is a focal area of full thickness destruction; ulcer is partial
C) Erosion involves partial focal loss of mucosa; ulcer involves full thickness destruction
D) Chronic peptic ulcer heals without scarring unlike erosions
E) Erosions are always caused by H. pylori; ulcers by NSAIDs
Erosion = partial focal loss of mucosa (less than full thickness); can progress to ulcer or heal without scarring. Ulcer = focal area of full thickness destruction of mucosa, extending through submucosa into the muscularis. This patient's NSAID use has caused acute gastritis with erosions. NSAIDs inhibit prostaglandins (protective) → decreased mucus secretion and mucosal blood flow → erosions. This is a key distinction on Step 1 — the depth of mucosal injury defines erosion vs. ulcer.
Question 5
A 55-year-old woman is found to have antibodies against H⁺/K⁺-ATPase and intrinsic factor. Upper endoscopy reveals atrophy of the gastric body with relative sparing of the antrum. Laboratory workup shows decreased HCl production, elevated serum gastrin, and B12 deficiency. Which of the following is a likely long-term complication unique to this condition (compared to H. pylori gastritis)?
A) Duodenal ulcer
B) Intestinal-type gastric adenocarcinoma
C) MALT lymphoma
D) Carcinoid tumor (gastric neuroendocrine tumor)
E) Hyperplastic polyps
This is autoimmune gastritis: antibodies to parietal cells (H⁺/K⁺-ATPase, intrinsic factor) → destruction of parietal cells → ↓ HCl → ↓ somatostatin inhibition of G cells → ↑ gastrin → ECL cell hyperplasia → carcinoid/neuroendocrine tumor risk. Also causes pernicious anemia (B12 deficiency from ↓ intrinsic factor). The body/fundus involvement with antrum-sparing distinguishes autoimmune from H. pylori (antrum-dominant). Duodenal ulcer (A), intestinal adenocarcinoma (B), MALT lymphoma (C), and hyperplastic polyps (E) are H. pylori sequelae.
Question 6
A 48-year-old man with a 10-year history of epigastric pain is found to have a 1.5 cm gastric ulcer on endoscopy. The ulcer has sharply defined, clean-cut edges with a flat base. Biopsy of the ulcer shows 4 microscopic layers: fibrinopurulent exudate, necrotic tissue, granulation tissue with fibroblasts, and scar tissue with thrombosed vessels. H. pylori testing is positive. Which of the following is the most appropriate treatment?
A) Antacids only to neutralize acid
B) H2-receptor antagonists indefinitely
C) Immediate surgical vagotomy
D) H. pylori eradication (triple therapy) plus proton pump inhibitor
E) No treatment — the ulcer will heal spontaneously
The 4-layer microscopic appearance (fibrinopurulent exudate → necrosis → granulation tissue → scar with thrombosed vessels) describes a chronic peptic ulcer. With confirmed H. pylori infection, the cornerstone of treatment is H. pylori eradication (triple therapy: PPI + 2 antibiotics, e.g., clarithromycin + amoxicillin) combined with a PPI. Eradicating H. pylori dramatically reduces ulcer recurrence. Antacids (A) only neutralize acid symptomatically. Vagotomy (C) is a historical procedure. The clean-cut flat edges confirm peptic ulcer (not cancer); biopsy was appropriately taken to rule out malignancy.
Question 7
A 40-year-old woman with severe recurrent peptic ulcers is found to have markedly elevated serum gastrin levels. Imaging reveals a 2 cm tumor in the pancreatic head. Which of the following best characterizes this condition?
A) Autoimmune gastritis with parietal cell antibodies
B) H. pylori-associated antral gastritis with duodenal ulcer
C) Zollinger-Ellison syndrome — gastrinoma causing severe peptic ulceration
D) Ménétrier disease with giant rugal hypertrophy and protein loss
E) MALT lymphoma of the stomach
Zollinger-Ellison (ZE) syndrome = gastrinoma (gastrin-producing tumor) of the pancreas, stomach, or intestine → severe peptic ulceration, often multiple, even in distal duodenum and jejunum. Marked hyperacidity. Gastrin is not normally produced in the pancreas — this is an ectopic tumor. ZE is one of the predisposing factors for PUD (#7 on the list). Associated with MEN-1 syndrome. Elevated serum gastrin (gastrinoma) + severe/multiple/refractory ulcers + pancreatic mass = classic ZE presentation.
Question 8
A 67-year-old man undergoes endoscopy for evaluation of weight loss and early satiety. The endoscopist notes that the stomach does not distend normally. Biopsy of the gastric wall reveals individual tumor cells with a central mucous droplet and peripherally displaced nucleus diffusely percolating throughout the tissue. Which is the most likely diagnosis?
A) Intestinal-type gastric adenocarcinoma
B) Linitis plastica (diffuse-type gastric adenocarcinoma) with signet ring cells
C) MALT lymphoma of the stomach
D) GIST with intact mucosal layer
E) Ménétrier disease with giant rugal hypertrophy
Linitis plastica is the classic diffuse-type gastric carcinoma (Lauren classification). Key features: (1) the entire stomach becomes rigid (non-distensible/"leather bottle") with no localized mass, (2) extensive fibrosis (more scar than tumor → makes biopsy difficult), (3) signet ring cells (central mucous droplet, peripherally displaced nucleus) diffusely percolating through the tissue. This is the diffuse type per Lauren — not associated with intestinal metaplasia, more common in young patients, uniformly distributed worldwide, poor prognosis. GIST (D) has intact mucosa and intact mucosal layer with white/fleshy appearance.
Question 9
A 58-year-old man with a history of chronic GERD develops gastric carcinoma. The tumor forms well-differentiated glands and grows as a well-demarcated mass in the gastric antrum. Which of the following features is most consistent with this tumor type under the Lauren classification?
A) Diffuse type — uniformly distributed worldwide, no association with intestinal metaplasia
B) Intestinal type — associated with intestinal metaplasia, predominant in high-incidence geographic areas
C) Diffuse type — signet ring cells, seen in young patients, better prognosis
D) Neither type — gastric carcinoma arising from peptic ulcer base
E) Intestinal type — uniformly distributed worldwide, mean age under 50
The intestinal type of gastric carcinoma (Lauren classification) forms glands, grows as a well-demarcated mass, is found predominantly in high-incidence areas (Japan, Chile, Finland), occurs in older males, and is strongly associated with intestinal metaplasia as a precursor. The diffuse type (A, C) shows signet ring cells, is uniformly distributed worldwide, occurs under age 50, and is NOT associated with intestinal metaplasia. Note: gastric carcinoma arises at the edge of a peptic ulcer, never at the base (D).
Question 10
A 50-year-old woman is diagnosed with a gastric submucosal mass on endoscopy. Biopsy reveals a mesenchymal tumor arising from the muscular wall with a specific immunohistochemical profile positive for c-KIT. The tumor projects into the lumen as a sessile mass. Which of the following is the most targeted treatment for this tumor?
A) Triple therapy for H. pylori eradication
B) Total gastrectomy with lymph node dissection
C) CHOP chemotherapy (cyclophosphamide, doxorubicin, vincristine, prednisone)
D) Imatinib (Gleevec) — c-KIT tyrosine kinase inhibitor
E) Radiation therapy alone
This is a classic presentation of a GIST (gastrointestinal stromal tumor) — c-KIT positive mesenchymal tumor arising from the muscular wall, projecting into the lumen as a sessile mass. The c-KIT gain-of-function mutation is the key molecular driver. Treatment with imatinib (Gleevec), a tyrosine kinase inhibitor targeting the c-KIT pathway, is highly effective even in metastatic disease. This was a landmark advance in targeted cancer therapy. Mitotic rate + size determine prognosis. H. pylori eradication (A) treats MALT lymphoma. CHOP (C) is for aggressive lymphomas.
Question 11
A 45-year-old man is diagnosed with gastric lymphoma. Biopsy shows lymphoid aggregates within the gastric mucosa consistent with a low-grade B-cell MALT lymphoma. H. pylori testing is positive. Which of the following is the most appropriate first-line treatment?
A) Imatinib to target c-KIT
B) H. pylori eradication with triple therapy
C) Radical gastrectomy
D) Rituximab (anti-CD20) monoclonal antibody
E) No treatment — gastric lymphoma has a better prognosis than carcinoma
This is a critical Step 1 teaching point: H. pylori eradication can sometimes CURE early low-grade MALT lymphomas. H. pylori drives lymphoid hyperplasia in the stomach (bacteria → overstimulation of MALT → MALToma risk). Removing the antigenic stimulus (H. pylori) by antibiotics can resolve early MALT lymphoma without chemotherapy or surgery. This is one of the few cancers where antibiotics serve as primary treatment. High-grade MALT lymphomas require chemotherapy (rituximab, D) but are less common. Imatinib (A) targets GIST, not lymphoma.
Question 12
A 29-year-old woman undergoes upper endoscopy for evaluation of epigastric pain and is found to have thickened gastric rugae throughout the proximal stomach with giant folds. Biopsy reveals greatly thickened mucous glands with cystic dilation. Laboratory workup shows hypoalbuminemia. Which precancerous condition is most consistent with these findings?
A) H. pylori-associated chronic atrophic gastritis with intestinal metaplasia
B) Autoimmune gastritis with pernicious anemia
C) Ménétrier disease with giant rugal hypertrophy and protein loss
D) Gastric adenoma with low-grade epithelial dysplasia
E) Zollinger-Ellison syndrome with gastrinoma
Ménétrier disease is characterized by: (1) giant rugal hypertrophy of the proximal stomach, (2) greatly thickened gastric folds, (3) increased mucous glands, and (4) protein-losing gastropathy → hypoalbuminemia + anemia. This is a precancerous condition that increases gastric cancer risk. Unlike H. pylori gastritis (A) which affects the antrum with inflammatory cells, Ménétrier involves the proximal stomach with mucous cell hypertrophy. Autoimmune gastritis (B) causes atrophy of the body with pernicious anemia, not giant rugal folds.
Question 13
A 72-year-old man with a known gastric peptic ulcer develops acute severe abdominal pain with rigidity. Imaging shows free air under the diaphragm. Which of the following best explains the pathophysiology of this complication?
A) Obstruction of the gastric outlet by scar tissue from the ulcer
B) Perforation of the ulcer through the full thickness of the gastric wall anteriorly, causing peritonitis
C) Hemorrhage from large vessel erosion at the ulcer base
D) Malignant transformation of the peptic ulcer to gastric carcinoma
E) Posterior penetration of the ulcer into the pancreas causing pancreatitis
Free air under the diaphragm (pneumoperitoneum) on imaging = perforation of a hollow viscus (peptic ulcer perforation in this context). Anterior perforation → no neighboring structure to plug the gap → gastric contents spill into the peritoneal cavity → severe peritonitis and profound shock (board buzzword). Perforation is more common in acute than chronic ulcers (scar tissue in chronic ulcers resists perforation). Posterior penetration (E) would enter the pancreas and cause pancreatitis without free air. Hemorrhage (C) would present with hematemesis/melena. Obstruction (A) causes progressive vomiting, not acute abdomen with free air.
Question 14
A 65-year-old man with GERD undergoes endoscopy and biopsy showing high-grade dysplasia in Barrett's esophagus. Which of the following is the most appropriate next step in management?
A) Continue surveillance endoscopy every 3 years
B) Start high-dose PPI therapy and repeat biopsy in 6 months
C) H. pylori eradication therapy
D) Endoscopic ablation/removal of the dysplastic mucosa
E) No intervention — dysplasia rarely progresses to carcinoma
The GERD → Barrett's → dysplasia → adenocarcinoma progression is well-established. Management by grade: Low-grade dysplasia = watch and wait / closer surveillance. High-grade dysplasia = ablation/removal (endoscopic mucosal resection, radiofrequency ablation, or esophagectomy depending on extent). High-grade dysplasia has significant risk of harboring or progressing to invasive adenocarcinoma. The majority of esophageal adenocarcinomas arise in Barrett's epithelium. Surveillance alone (A, B) is insufficient for high-grade dysplasia. H. pylori eradication (C) does not treat Barrett's.
Question 15
A pathologist examines a gastric biopsy from a 60-year-old immigrant from Japan who was found to have an asymptomatic gastric lesion on screening endoscopy. The biopsy shows gastric glands transformed to resemble intestinal mucosa with acid mucin-containing goblet cells throughout the specimen. Which of the following best describes this finding and its significance?
A) Acute gastritis — neutrophilic infiltrate; will resolve without treatment
B) Intestinal metaplasia — precancerous change associated with increased gastric cancer risk
C) Barrett's esophagus — goblet cells in the esophagus; increased adenocarcinoma risk
D) Gastric atrophy — loss of acid/pepsin glands; associated with pernicious anemia only
E) Chronic gastritis — chronic inflammatory cells; no malignant potential
Intestinal metaplasia = transformation of gastric glands to those resembling intestinal mucosa, namely acid mucin-containing goblet cells. This is a precancerous change associated with gastric carcinoma (especially intestinal type) at population, patient, and topographic levels. The Japanese patient context is important — Japan has among the highest gastric cancer incidence globally, and H. pylori-driven intestinal metaplasia is a major pathway. Conceptual parallel: intestinal metaplasia in the stomach ≈ Barrett's esophagus in the esophagus (both = columnar/goblet cell metaplasia under chronic mucosal injury). The pathway: H. pylori → chronic atrophic gastritis → intestinal metaplasia → dysplasia → carcinoma.